Item 16. Form 10-K Summary

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.


			LENNAR CORPORATION

			/S/ RICK BECKWITT
			Rick Beckwitt
			Co-Chief Executive Officer, Co-President and Director
			Date:			January 28, 2022


			LENNAR CORPORATION

			/S/ JONATHAN M. JAFFE
			Jonathan M. Jaffe
			Co-Chief Executive Officer, Co-President and Director
			Date:			January 28, 2022

Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:


Principal Executive Officer:

Rick Beckwitt	/S/ RICK BECKWITT
Co-Chief Executive Officer, Co-President and Director	Date:	January 28, 2022


Jonathan M. Jaffe	/S/ JONATHAN M. JAFFE
Co-Chief Executive Officer, Co-President and Director	Date:	January 28, 2022

Principal Financial Officer:

Diane Bessette	/S/ DIANE BESSETTE
Vice President, Chief Financial Officer and Treasurer	Date:	January 28, 2022

Principal Accounting Officer:

David Collins	/S/ DAVID COLLINS
Vice President and Controller	Date:	January 28, 2022

Directors:

Amy Banse	/S/ AMY BANSE
	Date:	January 28, 2022

Steven L. Gerard	/S/ STEVEN L. GERARD
	Date:	January 28, 2022

Theron I. ("Tig") Gilliam, Jr.	/S/ THERON I. ("TIG") GILLIAM, JR.
	Date:	January 28, 2022

Sherrill W. Hudson	/S/ SHERRILL W. HUDSON
	Date:	January 28, 2022

Sidney Lapidus	/S/ SIDNEY LAPIDUS
	Date:	January 28, 2022

Teri McClure	/S/ TERI MCCLURE
	Date:	January 28, 2022

Stuart Miller	/S/ STUART MILLER
	Date:	January 28, 2022

Armando Olivera	/S/ ARMANDO OLIVERA
	Date:	January 28, 2022

Jeffrey Sonnenfeld	/S/ JEFFREY SONNENFELD
	Date:	January 28, 2022

LENNAR CORPORATION AND SUBSIDIARIES

Schedule II—Valuation and Qualifying Accounts

Years Ended November 30, 2021, 2020 and 2019


			Additions
(In thousands)	Beginning balance		Charged to costs and expenses	Charged (credited) to other accounts	Deductions	Ending balance
Year ended November 30, 2021
Allowances deducted from assets to which they apply:
Allowances for credit losses and notes and other receivables	$	2,394	79	59	(1)	2,531
Allowance for loan losses and loans receivable	$	4,012	—	(31)	(1,890)	2,091
Allowance against net deferred tax assets	$	4,411	—	(1,556)	(162)	2,693
Year ended November 30, 2020
Allowances deducted from assets to which they apply:
Allowances for credit losses and notes and other receivables	$	3,379	661	(568)	(1,078)	2,394
Allowance for loan losses and loans receivable	$	4,122	795	17	(922)	4,012
Allowance against net deferred tax assets	$	4,341	70	—	—	4,411
Year ended November 30, 2019
Allowances deducted from assets to which they apply:
Allowances for credit losses and notes and other receivables	$	2,793	1,404	(344)	(474)	3,379
Allowance for loan losses and loans receivable	$	6,154	485	—	(2,517)	4,122
Allowance against net deferred tax assets	$	7,219	—	—	(2,878)	4,341

Previous: Item 15. Exhibit and Financial Statement Schedules.